Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES INC | 10-25-2023 | 09-30-2023 | 22420 | 1,288,125,066 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
PROTAGONIST THERAPEUTICS INC | COM | 15401 | $0 | 0 | 0.00 | 0.00 | 0 | NaN | 09-30-2023 |
PROTAGENIC THERAPEUTICS INC | COM | 15402 | $0 | 0 | 0.00 | 0.00 | 0 | NaN | 09-30-2023 |
PROTALIX BIOTHERAPEUTICS INC | COM | 15403 | $0 | 0 | 0.00 | 0.00 | 0 | NaN | 09-30-2023 |
PROSPECT CAPITAL CORPORATION | COM | 15404 | $0 | 0 | 0.00 | 0.00 | 0 | NaN | 09-30-2023 |